{"id":422,"date":"1997-10-01T12:05:00","date_gmt":"1997-10-01T10:05:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/neues-zu-arzneimittelnebenwirkungen"},"modified":"1997-10-01T12:05:00","modified_gmt":"1997-10-01T10:05:00","slug":"neues-zu-arzneimittelnebenwirkungen","status":"publish","type":"post","link":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/neues-zu-arzneimittelnebenwirkungen","title":{"rendered":"Neues zu Arzneimittelnebenwirkungen"},"content":{"rendered":"<p>Im folgenden soll \u00fcber einige Arzneimittel-Nebenwirkungen berichtet werden, die im British Medical Journal unter der \u00dcberschrift Drug Points regelm\u00e4\u00dfig publiziert werden. 1. Rhabdomyolyse bei Kombination von Ciprofibrat und Ibuprofen (Brit. Med. J. 1997, 314, 1593)Ein 29j\u00e4hriger Asiate mit schwerer Hyperlipid\u00e4mie wurde mit zun\u00e4chst 100 mg, sp\u00e4ter mit 200 mg Ciprofibrat\/d behandelt. Sechs Monate nach Behandlungsbeginn [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im folgenden soll \u00fcber einige Arzneimittel-Nebenwirkungen berichtet werden, die im British Medical Journal unter der \u00dcberschrift Drug Points regelm\u00e4\u00dfig publiziert werden. 1. Rhabdomyolyse bei Kombination von Ciprofibrat und Ibuprofen (Brit. Med. J. 1997, 314, 1593)Ein 29j\u00e4hriger Asiate mit schwerer Hyperlipid\u00e4mie wurde mit zun\u00e4chst 100 mg, sp\u00e4ter mit 200 mg Ciprofibrat\/d behandelt. Sechs Monate nach Behandlungsbeginn [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[255,146,451,508,449,398,507,139,142,509,455,453,502,510,292,140,456,149,257,279,503,111,291,115,114,506,505,443,504],"class_list":["post-422","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-arzneimittel","tag-brustkrebs","tag-cholesterinsynthese-hemmer","tag-ciprofibrat","tag-cse-hemmer","tag-doxazosin","tag-erektile-dysfunktion","tag-g-csf","tag-granulozyten-kolonien-stimulierender-faktor","tag-halluzinatorische-psychose","tag-hmg-coa-reduktase-hemmer","tag-hypercholesterinaemie","tag-ibuprofen","tag-impotenz","tag-lansoprazol","tag-lenograstim","tag-lipidsenker","tag-mammakarzinom","tag-medikamente","tag-mitoxantron","tag-nervus-opticus","tag-omeprazol","tag-pantoprazol","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-rhabdomyolyse","tag-simvastatin","tag-statine","tag-thymostimulin"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=422"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/422\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}